Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Ranolazine for Sale > High Quality 99% Ranolazine CAS 95635-55-5 Powder Fast Shipping Good Price
High Quality 99% Ranolazine CAS 95635-55-5 Powder Fast Shipping Good Price buy - large image1
High Quality 99% Ranolazine CAS 95635-55-5 Powder Fast Shipping Good Price buy - image1
High Quality 99% Ranolazine CAS 95635-55-5 Powder Fast Shipping Good Price buy - image2
High Quality 99% Ranolazine CAS 95635-55-5 Powder Fast Shipping Good Price buy - image3
High Quality 99% Ranolazine CAS 95635-55-5 Powder Fast Shipping Good Price buy - image4

High Quality 99% Ranolazine CAS 95635-55-5 Powder Fast Shipping Good Price

TDS

Unit Price: Get Latest Price
CAS No.:

95635-55-5

Grade:

Pharmaceutical Grade

Content:

99.5%

Port:

Hangzhou

Brand:

HyperChem

Packaging:

1kg/Bag

Price valid (until):

2025-01-03

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
10 days
Qualification:
Main Products:

Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements

  • Product Details

  • Seller Information

  • Description

    Name

    Ranolazine

    CAS number

    95635-55-5

    Synonym

    RANOLAZINE; 95635-55-5; Ranexa; CVT-303; RAN D; Ran4

    Description

    Ranolazine is an effective treatment option for the management of chronic stable angina, helping to improve exercise tolerance and reduce the frequency of angina episodes. Its unique mechanism of action distinguishes it from traditional antianginal therapies. As with all medications, careful patient selection, regular monitoring, and effective communication between patients and healthcare providers are essential in optimizing treatment outcomes and ensuring safety.

    Structure

    Shop High Quality 99% Ranolazine CAS 95635-55-5 Powder Fast Shipping Good Price-Detailed Image 1

    Molecular Formula

    C24H33N3O4

    Molecular Weight

    427.54 g/mol

    Appearance

    White powder

    Quality Standard

    99%

    Shipping Condition

    Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

    Storage Condition

    Dry, dark and at 2~8 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

    Shelf Life

    >2 years if stored properly

    Sample package

    Aluminium foil bag, Bottle

    Commercial package

    Aluminium Tin

    Origin

    China

    Ranolazine More Info

     

    Ranolazine is a medication primarily used for the treatment of chronic stable angina, a condition characterized by chest pain or discomfort due to reduced blood flow to the heart. It is classified as an antianginal agent and works through unique mechanisms that differentiate it from traditional therapies for angina.

    Mechanism of Action

    Ranolazine exerts its effects through several mechanisms:

    • Inhibition of Late Sodium Current : It selectively blocks late sodium channels in cardiac myocytes. This action helps to reduce intracellular calcium overload, thereby decreasing the oxygen demand of the heart muscle.
    • Improvement of Myocardial Metabolism : Ranolazine enhances the efficiency of glucose utilization in the heart, which can improve cardiac energy production, especially during periods of ischemia (inadequate blood supply).
    • Enhancement of Diastolic Function : By alleviating myocardial ischemia, ranolazine may help improve diastolic function, contributing to better coronary blood flow and reduced angina symptoms.

    Indications

    Ranolazine is approved for:

    • Chronic Stable Angina : It is indicated for the treatment of chronic angina, either alone or in combination with other antianginal medications such as beta-blockers or calcium channel blockers. It is particularly beneficial for patients who do not achieve adequate symptom relief from traditional therapies.

    Dosage and Administration

    Ranolazine is available in an extended-release formulation, typically administered orally. The standard dosing regimen generally starts with a lower dose that can be gradually increased based on the patient’s response and tolerance. It is designed to be taken twice daily, with or without food.

    Side Effects

    Common side effects of ranolazine may include:

    • Dizziness
    • Headache
    • Nausea
    • Constipation
    • Fatigue
    • Palpitations (irregular heartbeats)

    Serious adverse effects, while rare, can include:

    • QT Interval Prolongation : Ranolazine has been associated with prolonging the QT interval on the ECG, which can increase the risk of life-threatening arrhythmias.
    • Hepatic Dysfunction : Since ranolazine is metabolized in the liver, it may lead to liver enzyme elevations, requiring monitoring of hepatic function.

    Contraindications and Cautions

    Ranolazine may not be suitable for all patients, and specific considerations include:

    • Hypersensitivity : Individuals with known hypersensitivity to ranolazine should avoid using it.
    • Drug Interactions : Caution is needed when ranolazine is prescribed with other medications that prolong the QT interval or are known to interact with the CYP3A enzyme system.
    • Severe Liver Impairment : Ranolazine is contraindicated in patients with significant liver dysfunction, as altered metabolism can lead to increased drug levels and potential toxicity.
    • Renal Impairment : It should be used cautiously in patients with renal dysfunction, and adjustments in dosing may be necessary.

    Clinical Considerations

    Patients taking ranolazine should have regular follow-ups to evaluate the effectiveness of the treatment and monitor for any side effects. Education regarding the importance of adhering to prescribed doses and being aware of potential side effects, especially those related to heart rhythm disturbances, is essential.

    Conclusion

    Ranolazine represents an effective option for the management of chronic stable angina, distinguishing itself from traditional antianginal therapies through its unique mechanisms of action. Proper patient assessment, monitoring, and healthcare provider communication are crucial to ensuring optimal treatment outcomes and minimizing risks associated with its use.


    Product Image

    Shop High Quality Oxytocin CAS 50-56-6-Detailed Image 2

    Shop USP Quality Standard API Finasteride Powder with CAS 98319-26-7-Detailed Image 3



    FAQ


    Q1. Can I get a free sample?

    We can send you a samll free sample, and you only need to pay for the shipping cost.

     

    Q2. What is the HyperChem payment term?

    T/T in advance
    LC at sight
    DP at sight

    Bank transfer

    PayPal

    Bitcoin...

     

    Q3. What is HyperChem shipment policy?

    Our policy is to strive for the quickest shipment time possible.

    For ready stock samples, they are usually shipped within 3 working days after payment received.
    For non-ready stock, please contact HyperChem sales team to negotiate.

     

    Q4. What is HyperChem shipment term?

    By Express  
    FedEx  UPS  DHL  EMS                               
    Fast: 3-7 days around, high cost, door to door service

    By Air                                        
    Suitable for more than 50kg 
    Fast: 3-7 days, hight cost, port to port, professional broker needed 

    By Sea
    Suitable for more than 500kg      
    Fast: 7-45 days, low cost, port to port, professional broker needed 

     

    We will always attempt to utilize the quickest and most affordable way for customers to receive orders. And follow -up with customers via email for all shipment details as well as updated track information until it arrives without damage.

     

    Q5. What HyperChem will provide after shipment?

    For sample orders: 
    After shipment is done, an timely email including:

    1. Track details (Fedex /TNT/DHL/EMS Track number)
    2. Packaging photo
    3. COA, MSDS, etc
    4. Dispatch date & Estimated arriving time
    5. Shipping invoice

    For commercial orders:
    A full set of shipment documents as well as package photos can be provided in scan-copy and original, to help customers complete the customs clearance process.

    ECHEMI Editorial Reference
    Ranolazine is an antianginal medication.Target: Sodium ChannelRanolazine is believed to have its effects via altering the transcellular late sodium current. It affects the sodium-dependent calcium channels during myocardial ischemia in rabbits by altering the intracellular sodium level [1]. Thus, ranolazine indirectly prevents the calcium overload that causes cardiac ischemia in rats [2]. The effects of ranolazine on the NaV 1.7 and NaV 1.8 sodium channels also make it potentially useful
    Solid
    N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide is an aromatic amide obtained by formal condensation of the carboxy group of 2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetic acid with the amino group of 2,6-dimethylaniline. It is a monocarboxylic acid amide, an aromatic amide, a N-alkylpiperazine, a secondary alcohol and a monomethoxybenzene.|Chronic angina is a common cardiovascular condition affecting millions worldwide and causes significant disability while interfering with daily activities. Ranolazine is a well-tolerated piperazine derivative used for the management of this condition, offering relief from uncomfortable and debilitating symptoms. With a mechanism of action different from drugs used to treat the same condition, ranolazine is a promising anti-anginal therapy. It was originally approved by the FDA in 2006.|Ranolazine is a unique, orally available antiangina agent. Chronic ranolazine therapy has not been associated with serum enzyme elevations, but has been linked to rare cases of mild, clinically apparent liver injury.|An acetanilide and piperazine derivative that functions as a SODIUM CHANNEL BLOCKER and prevents the release of enzymes during MYOCARDIAL ISCHEMIA. It is used in the treatment of ANGINA PECTORIS.

    Certificates

    Basic Info
    Product Name:

    Ranolazine

    Other Name:

    1-Piperazineacetamide,N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-;1-Piperazineacetamide,N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-,(±)-;N-(2,6-Dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazineacetamide;(±)-Ranolazine;Ranolazine;CVT 303;Ranexa;RS 43285-003;Renexa;4-(Pyrimidin-2-ylmethyl)-7-(4-(trifluoromethyl)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one;142387-99-3

    CAS No.:

    95635-55-5

    Molecular Formula:

    C24H33N3O4

    InChIKeys:

    InChIKey=XKLMZUWKNUAPSZ-UHFFFAOYSA-N

    Molecular Weight:

    427.54

    Exact Mass:

    427.54

    EC Number:

    1308068-626-2

    NSC Number:

    759100

    DSSTox ID:

    DTXSID3045196

    Color/Form:

    White to off-white solid

    ATC Code:

    C01EB18|C - Cardiovascular system

    HScode:

    2933990090

    Categories:

    Other Chemical Drugs

    Characteristics
    PSA:

    74.3

    XLogP3:

    2.7

    Appearance:

    Solid

    Density:

    1.2±0.1 g/cm3

    Melting Point:

    119-1200C

    Boiling Point:

    624.1°C at 760 mmHg

    Flash Point:

    331.2±31.5 °C

    Refractive Index:

    1.586

    Water Solubility:

    H2O: Very slightly soluble

    Storage Conditions:

    -20°C Freezer

    Vapor Pressure:

    4.56X10-16 mm Hg at 25 deg C (est)

    PKA:

    2.2None

    Henrys Law Constant:

    Henry's Law constant = 3.56X10-22 atm-cu m/mol at 25 °C (est)

    Dissociation Constants:

    2.2

    Collision Cross Section:

    205.2 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]

    Experimental Properties:

    MW: 500.46 White to crystalline powder from methanol/ether; mp 164-166 °C. Readily soluble in water. /Dihydrochloride/|Hydroxyl radical reaction rate constant = 2.47X10-10 cu cm/molec-sec at 25 °C (est)

    Hazard Identification

    Classification of the substance or mixture

    Acute toxicity - Category 4, Oral

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H302 Harmful if swallowed

    Precautionary statement(s)
    Prevention

    P264 Wash ... thoroughly after handling.

    P270 Do not eat, drink or smoke when using this product.

    Response

    P301+P317 IF SWALLOWED: Get medical help.

    P330 Rinse mouth.

    Storage

    none

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements

    Location:

    Rm. 803, Tower 4, LOFT49 Creative City Pioneer Zone, No.88 Jiru Rd. Gongshu Dist., Hangzhou, 310015 ZJ, China

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    10 days

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    11-50

    Year of Establishment:

    2013

    Company Certificates
    • Hangzhou Hyper Chemicals LimitedCertification Report by Bureau Veritas Certification Report by Bureau Veritas
    About HyperChem

    Established in 2013, Hyper Chem has exclusive tie-ups with leading manufacturers, supplying raw materials produced in GMP and ISO 9002 certified facilities, and provides high-quality ingredients and raw materials to meet the needs of a diverse range of pharmaceutical cosmetics ingredients and nootropic supplements companies worldwide.

    Our Competitiveness

    One-stop supply

    Wide Range Of products including pharmaceutical, Cosmetic Ingredients and nootropic supplements

    Among all the pharmaceuticals,

    90% of them with GMP certificates,

    85% of them with DMF files and

    50% of them passed FDA approval,

    30% get CEP certificate

    20% are new R&D products.

    Custom Repackaging Service


    We can efficiently repackage your material into sample sizes, custom batch-specific sizes, or semi-bulk package sizes according to your specifications. And ensures the product is packaged in a quality-controlled environment and will maintain its integrity throughout every stage of the process.

    Quality Control/Quality Assurance


    HyperChem is committed to delivering on its promises of top-quality products with verified quality data.

    All materials are vigorously inspected by the factory and/or outsourced analytical laboratories to ensure each and every lot meets or exceeds our reference standards.

    Trade assurance service with 100% payment protection, It is best achieved by delivering products and services 100% right the first time, on time, every time.

    Professional

    Transparent Communication

    Fast Reaction,

    Professional Suggestion

    Beyond Expectation.

    We have exclusive partnerships with research and production facilities across the country and we offer varied pharmaceutical services in the most cost-efficient way. The production facilities are GMP, WHO-GMP, EU GMP and US FDA approved and are backed by strong regulatory support such as Dossier, DMF, Tech Pack and relevant Stability studies for regulatory filings.

  • Country Product Purchase Quantity Date Posted
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.